The outlook for children with respiratory complications of neuromuscular disease has improved significantly in the past 15 years. This has been the result of many advances in clinical care, including improved monitoring of lung function and hypoventilation during sleep; coordinated respiratory care by experienced physicians with access to specialized respiratory services, especially physiotherapy; and, most importantly, the widespread introduction of noninvasive ventilation.J. Declan Kennedy and A. James Marti
BACKGROUND: Patients with chronic neuromuscular disease represent less than 10 % of those receiving ...
Neuromuscular diseases (NMD) can affect all major respiratory muscles, leading to the development of...
Children with hereditary neuromuscular diseases (NMDs) are at a high risk of morbidity and mortality...
Patients with neuromuscular diseases (NMDs) suffer from respiratory muscle weakness, resulting in re...
Background: Non-invasive positive pressure ventilation (NPPV) has a beneficial effect on nocturnal h...
Acute respiratory failure (ARF) is a common cause of morbidity and mortality in most advanced neurom...
Objective: To assess the role of physiotherapy in approaching neuromuscular disease (NMD), with emph...
Background and objective: In the last 20 years, research efforts have been focused on the use of non...
Neuromuscular disorders (NMD) such as Duchenne Muscular Dystrophy (DMD) are characterised by slow pr...
Objective: Respiratory management of patients with end-stage respiratory muscle failure of neuromusc...
SummaryBackgroundRespiratory failure is the most common cause of morbidity and mortality in patients...
Background: Use of long-term non-invasive positive pressure ventilation is increasing greatly worldw...
OBJECTIVE: Respiratory management of patients with end-stage respiratory muscle failure of neuromusc...
Three patients with myotonic dystrophy (MD) developed respiratory failure. The first was a 55-year-o...
Objectives To determine: (a) prevalence of clinically unsuspected nocturnal hypoventilation (NH) in ...
BACKGROUND: Patients with chronic neuromuscular disease represent less than 10 % of those receiving ...
Neuromuscular diseases (NMD) can affect all major respiratory muscles, leading to the development of...
Children with hereditary neuromuscular diseases (NMDs) are at a high risk of morbidity and mortality...
Patients with neuromuscular diseases (NMDs) suffer from respiratory muscle weakness, resulting in re...
Background: Non-invasive positive pressure ventilation (NPPV) has a beneficial effect on nocturnal h...
Acute respiratory failure (ARF) is a common cause of morbidity and mortality in most advanced neurom...
Objective: To assess the role of physiotherapy in approaching neuromuscular disease (NMD), with emph...
Background and objective: In the last 20 years, research efforts have been focused on the use of non...
Neuromuscular disorders (NMD) such as Duchenne Muscular Dystrophy (DMD) are characterised by slow pr...
Objective: Respiratory management of patients with end-stage respiratory muscle failure of neuromusc...
SummaryBackgroundRespiratory failure is the most common cause of morbidity and mortality in patients...
Background: Use of long-term non-invasive positive pressure ventilation is increasing greatly worldw...
OBJECTIVE: Respiratory management of patients with end-stage respiratory muscle failure of neuromusc...
Three patients with myotonic dystrophy (MD) developed respiratory failure. The first was a 55-year-o...
Objectives To determine: (a) prevalence of clinically unsuspected nocturnal hypoventilation (NH) in ...
BACKGROUND: Patients with chronic neuromuscular disease represent less than 10 % of those receiving ...
Neuromuscular diseases (NMD) can affect all major respiratory muscles, leading to the development of...
Children with hereditary neuromuscular diseases (NMDs) are at a high risk of morbidity and mortality...